CD79A and renal cell carcinoma: Evidence from KEGG pathway enrichment analysis and GSEA indicated that RSPO1 participates in a number of different biological processes, including the cell cycle, Hippo pathway, intestinal immune network for IgA production, p53 signaling pathway, toll-like receptor signaling pathway, renal cell carcinoma, and colorectal cancer.